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Poly-ubiquitylation is a common post-translational mod-
iﬁcation that can impart various functions to a target
protein. Several distinct mechanisms have been reported
for the assembly of poly-ubiquitin chains, involving either
stepwise transfer of ubiquitin monomers or attachment of
a preformed poly-ubiquitin chain and requiring either a
single pair of ubiquitin-conjugating enzyme (E2) and
ubiquitin ligase (E3), or alternatively combinations of
different E2s and E3s. We have analysed the mechanism
of poly-ubiquitylation of the replication clamp PCNA by
two cooperating E2–E3 pairs, Rad6–Rad18 and Ubc13–
Mms2–Rad5. We ﬁnd that the two complexes act sequen-
tially and independently in chain initiation and stepwise
elongation, respectively. While loading of PCNA onto DNA
is essential for recognition by Rad6–Rad18, chain exten-
sion by Ubc13–Mms2–Rad5 is only slightly enhanced
by loading. Moreover, in contrast to initiation, chain
extension is tolerant to variations in the attachment site
of the proximal ubiquitin moiety. Our results provide
information about a unique conjugation mechanism that
appears to be specialised for a regulatable pattern of dual
modiﬁcation.
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Introduction
Like other post-translational modiﬁers, the small, highly
conserved protein ubiquitin mediates its biological functions
by reversibly altering the properties of its targets
(Ciechanover et al, 2000; Hochstrasser, 2000). However, un-
like simple modiﬁcations such as methylation or acetylation,
ubiquitylation has the potential for a widely expanded range
of signalling by means of its ability to form polymeric chains
(Pickart and Fushman, 2004; Ikeda and Dikic, 2008). Despite the
signiﬁcance of poly-ubiquitylation for cellular regulation and the
abundance of poly-ubiquitylated substrates, surprisingly little
is known about the mechanism of ubiquitin chain assembly
(Hochstrasser, 2006). Both mono- and poly-ubiquitylation are
mediated by a cascade of enzymes, involving activation of
ubiquitin as a high-energy thioester intermediate by an
activating enzyme (E1), transfer of the ubiquitin thioester
to a conjugating enzyme (E2) and attachment of ubiquitin’s
carboxyl (C)-terminus to a lysine residue in the target protein
with the help of a ubiquitin protein ligase (E3) (Kerscher et al,
2006). Whereas in the case of mono-ubiquitylation, E3
is generally responsible for selecting one or more lysines
directly on the substrate for ubiquitin conjugation, poly-
ubiquitylation requires formation of at least two distinct
types of linkage, that between the substrate and the proximal
ubiquitin and those between the individual ubiquitin
moieties within the chain. Mechanistic studies of selected
conjugation factors have shown that this task can be accom-
plished in several distinct ways. As exempliﬁed by the action
of the ubiquitin ligase SCF
Cdc4 with the E2 Cdc34 on the
cyclin inhibitor Sic1 (Petroski and Deshaies, 2005) or the
human anaphase-promoting complex (APC) with the E2
UbcH10 on securin or cyclin-B1 (Jin et al, 2008), a single
E2–E3 pair is able to mediate both initiation and elongation of
the ubiquitin chain. In contrast, budding-yeast APC or the
virally encoded ligase K3 sequentially cooperate with two
distinct E2s for mono-ubiquitylation and chain extension
(Duncan et al, 2006; Rodrigo-Brenni and Morgan, 2007).
Whereas in these examples the poly-ubiquitin chain is pre-
sumably assembled in a stepwise manner, some E2s, such as
the human Ube2g2 or yeast Ubc7, are capable of preforming
poly-ubiquitin chains on their active-site cysteine (Li et al,
2007; Ravid and Hochstrasser, 2007). Ube2g2 then transfers
these en bloc onto a substrate protein. In a variation of
this mechanism, the conjugating enzyme E2-25K is able to
use unanchored poly-ubiquitin chains activated by E1
(Piotrowski et al, 1997).
Modiﬁcation of the eukaryotic replication clamp PCNA in
the context of DNA damage tolerance is as of now the only
reported case where separate E2–E3 pairs appear to be
responsible for mono- and poly-ubiquitylation of a common
substrate (Moldovan et al, 2007; Ulrich, 2009). In response to
DNA-damaging agents, PCNA is mono-ubiquitylated at a
single, conserved lysine, K164, by the E2 Rad6 in complex
with the RING-ﬁnger E3 Rad18, whereas poly-ubiquitylation
at the same site additionally requires the heterodimeric E2
Ubc13–Mms2 and a second RING-ﬁnger E3, Rad5 (Hoege
et al, 2002). As a consequence, rad5, ubc13 and mms2
mutants can mono-, but not poly-ubiquitylate, PCNA,
whereas in rad6 and rad18 mutants, ubiquitylation is com-
pletely abolished. The two modiﬁcations label PCNA for
alternative functions: mono-ubiquitylation activates transle-
sion synthesis through damage-tolerant DNA polymerases
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3657(Stelter and Ulrich, 2003; Kannouche et al, 2004; Watanabe
et al, 2004), and poly-ubiquitylation is required for an error-
free pathway of damage avoidance possibly involving a
template switch (Hoege et al, 2002; Zhang and Lawrence,
2005).
Poly-ubiquitin chain assembly by Ubc13–Mms2 has been
studied in detail (Hofmann and Pickart, 1999, 2001; McKenna
et al, 2001, 2003; Moraes et al, 2001; VanDemark et al, 2001;
Eddins et al, 2006; Yin et al, 2009). The Ubc13–Mms2
complex is unusual among E2 enzymes in that it polymerises
ubiquitin exclusively through lysine 63 (Hofmann and
Pickart, 1999), its speciﬁcity dictated by a ubiquitin-binding
site within the Mms2 subunit (Moraes et al, 2001; VanDemark
et al, 2001; Eddins et al, 2006). Moreover, it is particularly
active at catalysing the synthesis of free, unanchored chains
(Hofmann and Pickart, 1999, 2001). In contrast, the mechan-
ism of cooperation between the two E2–E3 pairs with PCNA
as a substrate has not been addressed. In addition to inter-
acting with their cognate E2s, both Rad18 and Rad5 interact
with PCNA, with each other and with themselves (Bailly
et al, 1994; Ulrich and Jentsch, 2000; Hoege et al, 2002).
These interrelations suggest several alternative models of
how the enzymes may cooperate in PCNA poly-ubiquityla-
tion. The models, shown schematically in Figure 1, differ
with respect to the questions of whether the two E2–E3 pairs
act sequentially (A, B) or in concert (C, D), and whether the
ubiquitin moieties are added in a stepwise manner (A, C) or
transferred en bloc to PCNA (B, D). We have now reconsti-
tuted the poly-ubiquitylation of budding-yeast PCNA with
puriﬁed components in order to differentiate between these
models. In addition, we have analysed the relevance of DNA
and the ubiquitin attachment site for the process. Our
results lend support to model A where Rad6–Rad18 and
Ubc13–Mms2–Rad5 act sequentially and mediate PCNA poly-
ubiquitylation by stepwise addition of ubiquitin monomers.
Results
In vitro reconstitution of PCNA poly-ubiquitylation
In order to analyse the mechanism of PCNA poly-ubiquityla-
tion, Rad5 and the Rad6–Rad18 complex were puriﬁed from
Saccharomyces cerevisiae strains overexpressing the relevant
genes. Bovine ubiquitin and recombinant human E1 were
obtained from commercial sources, and PCNA, Ubc13 and
Mms2 were produced in Escherichia coli. Rad5, Rad18 and
Ubc13 were produced with an N-terminal His6-epitope to aid
puriﬁcation. Previous studies had indicated that budding-
yeast Rad18 is active only towards PCNA that is loaded
onto DNA (Garg and Burgers, 2005). We, therefore, included
a nicked plasmid and recombinant clamp loader, Replication
Factor C (RFC), in our reactions. Figure 2A shows efﬁcient
poly-ubiquitylation of PCNA in the presence of all compo-
nents, in accordance with analogous experiments using
human enzymes (Unk et al, 2006, 2008). High-molecular-
weight species of PCNA were produced under these condi-
tions, indicating assembly of long poly-ubiquitin chains on
the loaded clamp. As expected from the behaviour of the
respective mutants in vivo, Rad6–Rad18 alone produced
mono-ubiquitylated PCNA, and omission of Rad6–Rad18
from the reaction prevented both mono- and poly-ubiquityla-
tion. The conﬁnement to mono-ubiquitylated PCNA in reac-
tions containing a K63R mutant of ubiquitin conﬁrmed the
Figure 1 Alternative models for the mechanism of PCNA poly-ubiquitylation by Rad6–Rad18 and Ubc13–Mms2–Rad5. (A) Sequential action,
stepwise assembly: Rad6–Rad18 and Ubc13–Mms2–Rad5 act independently and sequentially, each attaching the ubiquitin moieties in a
stepwise manner. After conjugation of the ﬁrst ubiquitin, Rad6–Rad18 is no longer required, and Rad5 recognises the mono-ubiquitylated
PCNA as a substrate for chain elongation through K63. (B) Sequential action, preformed chains: Rad6–Rad18 and Ubc13–Mms2–Rad5 act
independently and sequentially. A K63-linked poly-ubiquitin chain is assembled by Ubc13–Mms2–Rad5 and transferred en bloc to the mono-
ubiquitylated PCNA. The chain may be assembled either free in solution or as a thioester on the active-site cysteine of Ubc13. (C) Separate
complexes, stepwise assembly: A dedicated Rad6–Rad18 complex mono-ubiquitylates PCNA. Independently, a complex containing Rad6,
Rad18, Ubc13, Mms2 and Rad5 mediates K63-poly-ubiquitylation. Rad6–Rad18 within this complex attaches the ﬁrst ubiquitin moiety and
enhances the contact of PCNA to Ubc13–Mms2–Rad5, which catalyses chain elongation in a stepwise manner. (D) Separate complexes,
preformed chains: As in model C, a dedicated Rad6–Rad18 complex mediates PCNA mono-ubiquitylation. A separate Rad6–Rad18–Ubc13–
Mms2–Rad5 complex poly-ubiquitylates PCNA by the assembly of a K63-linked poly-ubiquitin chain through Ubc13–Mms2–Rad5, which is
then transferred en bloc to PCNA by Rad6–Rad18.
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low amount of di-ubiquitylated PCNA in the absence of Rad5,
indicating that Ubc13–Mms2 was marginally active towards
mono-ubiquitylated PCNA even without its cognate E3. Taken
together, these results are consistent with in vivo data in-
dicating requirement of Rad6–Rad18 for K63 poly-ubiquityla-
tion of PCNA by Ubc13–Mms2–Rad5, but they do not allow
distinction between the different models depicted in Figure 1.
In order to assess the kinetics of chain formation on PCNA,
we, therefore, followed a time course of poly-ubiquitylation
in reactions that had been preincubated with Rad6–Rad18.
Figure 2B shows chains of intermediate lengths at early time
points that were chased into higher molecular weight species
in the course of the reaction. This pattern appears to indicate
a stepwise addition of ubiquitin monomers according to
models A and C. However, we cannot exclude a combination
of stepwise and en-bloc transfer, as the di- and tri-ubiquity-
lated forms of PCNA may well have been converted to higher
forms by the addition of a chain instead of monomers.
Continued presence of Rad18 is not required
for poly-ubiquitin chain extension on PCNA
The interaction between Rad18 and Rad5 suggests that they
might act as a complex in PCNA poly-ubiquitylation, accord-
ing to models C and D (Ulrich and Jentsch, 2000). In this
case, presence of Rad18 would be required throughout the
poly-ubiquitylation reaction, either to enhance the contact
between PCNA and Ubc13–Mms2–Rad5 (model C) or for
catalytic transfer of an entire poly-ubiquitin chain (model
D). Alternatively, Rad6–Rad18 might solely be required to
attach the ﬁrst ubiquitin moiety onto PCNA. In the latter case,
the complex would be dispensable for the subsequent action
of Ubc13–Mms2–Rad5 (models A and B). In order to distin-
guish between these possibilities, we used a puriﬁed prepara-
tion of partially mono-ubiquitylated PCNA in chain extension
reactions either containing or lacking Rad6–Rad18. Figure 3A
shows that the extent of poly-ubiquitylation as judged by the
disappearance of mono-ubiquitylated PCNA and the appear-
ance of higher molecular weight forms was unaffected by the
Rad6–Rad18 complex. This was true both in the presence of
DNA and RFC, where Rad6–Rad18 is in principle capable of
modifying PCNA, and in their absence, where Rad18 would
interact with PCNA and Rad5 without being able to modify
the clamp (Figure 3A). Titration of the concentration of
Rad6–Rad18 in the reaction conﬁrmed that the complex
had no effect on the activity of Ubc13–Mms2–Rad5 towards
mono-ubiquitylated PCNA (Figure 3B). Intriguingly, the un-
modiﬁed PCNA in the preparation was not further ubiquity-
lated by the newly added Rad6–Rad18. We suspect that this
may be due to either a failure to modify PCNAwithin a trimer
already bearing one or two ubiquitin moieties, or simply due
to the low concentration of unmodiﬁed PCNA in the reaction.
Along a similar line of observation, Rad6–Rad18 was pre-
viously reported to be rather sensitive to the scale of the
reaction (Garg and Burgers, 2005). Overall, however, our data
suggest that despite their physical interactions, the two E2–E3
pairs, Rad6–Rad18 and Ubc13–Mms2–Rad5, act sequentially
and independently of each other, in support of models A and
B (Figure 1).
Loading of PCNA onto DNA enhances the efﬁciency
of PCNA poly-ubiquitylation
A second important conclusion from the experiments shown
in Figure 3A and B is that chain elongation by Ubc13–Mms2–
Rad5—in contrast to Rad6–Rad18-dependent mono-ubiquity-
lation—does not require PCNA to be loaded onto DNA.
Nevertheless, comparison of the modiﬁcation efﬁciencies in
the presence and absence of DNA and RFC (Figure 3A)
indicated that loading of PCNA might stimulate the poly-
Figure 2 In vitro reconstitution of PCNA poly-ubiquitylation.
(A) Modiﬁcation of PCNA by mono- and poly-ubiquitylation
using puriﬁed enzymes. Reactions were performed in the presence
of a nicked plasmid and the clamp loader RFC in order to provide
loaded PCNA as a substrate. All reactions contained E1 and ATP.
Enzymes for PCNA mono-ubiquitylation (Rad6–Rad18) were added
ﬁrst where indicated and the reaction mixture was incubated for
40min at 301C before addition of the poly-ubiquitylation factors
(Ubc13–Mms2–Rad5) where indicated and further incubation for
40min. Replacement of ubiquitin by a K63R mutant is indicated as
‘R’. Products were detected by Western blotting with a PCNA-
speciﬁc antibody. Asterisks indicate cross-reactive bands visible
upon prolonged exposure of the blots. (B) Time course of the
poly-ubiquitylation reaction. Reactions were set up with the
mono-ubiquitylation enzymes as described above, and Ubc13,
Mms2 and Rad5 were added after a 60min incubation at 301C.
Starting from this point, samples were taken at the indicated times
and analysed by Western blotting as above.
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Rad5, like Rad18, is a DNA-binding protein (Johnson et al,
1994), a similar behaviour would not be surprising. In order
to verify that the observed stimulation was really due to
PCNA loading and not to the mere presence of either DNA or
RFC, we repeated the chain extension reactions, adding DNA
and RFC separately (Figure 3C). Based on the depletion of the
mono-ubiquitylated substrate, we found that stimulation of
the reaction required both DNA and RFC, suggesting that
mono-ubiquitylated PCNA is a better substrate for Ubc13–
Mms2-Rad5 when residing on DNA than free in solution.
Surprisingly, while RFC alone had no effect, addition of DNA
alone reproducibly resulted in slight inhibition of PCNA poly-
ubiquitylation. This effect might be due to sequestering of
Rad5 on DNA, which could render modiﬁcation of soluble
PCNA less efﬁcient. Importantly, however, the scaffolding
function of DNA that was found indispensable for mono-
ubiquitylation by Rad6–Rad18 appears to be beneﬁcial, but
not essential, for the activity of Rad5 towards PCNA.
Rad5 tolerates variations in the site of ubiquitin
attachment on PCNA
In the absence of PCNA, Rad5 strongly stimulates the synth-
esis of unanchored poly-ubiquitin chains by Ubc13-Mms2
(Figure 4A). By means of its interaction with PCNA, Rad5
may therefore simply act as an enhancer of E2 activity that
mediates proximity of the Ubc13–Mms2 complex to the
substrate. Alternatively, Rad5 may be involved in the speciﬁc
recognition of PCNA mono-ubiquitylated at K164. In order to
determine to what extent Rad5 is selective with respect to the
site of modiﬁcation on PCNA, we generated fusions of
ubiquitin to the N- or C-terminus of PCNA as artiﬁcially
‘mono-ubiquitylated’ substrates. As shown in Figure 4B and
C, both constructs were modiﬁed by Ubc13–Mms2–Rad5.
This indicates that Rad5 does not require the ﬁrst ubiquitin
moiety to be attached to a speciﬁc site on PCNA. However,
the two constructs were modiﬁed with very different efﬁcien-
cies. The fusion protein bearing ubiquitin at its N-terminus
was virtually depleted in the course of a 30-min reaction, thus
exhibiting substrate qualities comparable to or even better
than the physiologically K164-modiﬁed PCNA (Figure 4B). In
contrast, modiﬁcation of the C-terminal fusion was rather
inefﬁcient (Figure 4C). Although the inefﬁciency of Ubc13–
Mms2–Rad5 towards the C-terminal fusion construct could
possibly indicate some preference with respect to the mod-
iﬁcation site, it is more likely due to the arrangement of the
fusion partners: as K63 is spatially adjacent to the N-terminus
of ubiquitin, modiﬁcation at this site could easily be impeded
by a partial obstruction by means of the fusion. Time-course
and titration experiments with the N-terminal fusion protein
again showed a stimulatory effect of PCNA loading
(Figure 4D and E). Interestingly, we also observed inhibition
of poly-ubiquitylation by concentrations of RFC approaching
stoichiometric amounts in the absence of DNA (Figure 4E). It
is unclear whether this effect was due to an inability of
Ubc13–Mms2–Rad5 to modify PCNA in the ring-opened
conformation or whether RFC simply sequestered the clamp
away from the modifying enzymes.
Rad18 and Rad5 can catalyse the transfer of
preassembled poly-ubiquitin chains onto PCNA
Models B and D (Figure 1) postulate a Ube2g2-like mechan-
ism in which the E2 transfers an entire poly-ubiquitin chain
en bloc to a substrate (Li et al, 2007). In the case of Ube2g2,
the chain is built as a thioester upon the active-site cysteine of
the E2 (Li et al, 2007); however, other E2s such as E2-25K are
also known to accept activated preassembled chains from E1
(Piotrowski et al, 1997). In order to establish whether a
similar mechanism could apply to mono- and/or poly-ubi-
quitylation of PCNA, we assessed the ability of the two E2–E3
pairs to accept and transfer ubiquitin dimers and tetramers of
different linkages. A prerequisite for this activity is the ability
of the E2 to form a thioester with the respective ubiquitin
derivatives. Figure 5A shows that Rad6 formed thioesters
with wild-type (WT) ubiquitin, a K63R mutant and di-ubi-
quitin of K48- and K63-linkage with comparable efﬁciency.
Tetra-ubiquitin of K48 linkage was accepted equally well, and
only K63-linked tetra-ubiquitin was used less efﬁciently for
thioester formation. The presence of Rad18 did not signiﬁ-
cantly affect this pattern (Supplementary Figure S1A).
Figure 3 Inﬂuence of Rad6–Rad18 and DNA/RFC on PCNA poly-ubiquitylation. (A) Rad6–Rad18 is dispensable for chain extension by Ubc13–
Mms2–Rad5. Puriﬁed, partially mono-ubiquitylated PCNA was used in reactions containing Rad5, Ubc13 and Mms2 where indicated. All
reactions contained E1 and ATP, and Rad6–Rad18 was added where indicated. The assay was performed both in the presence and absence of
nicked plasmid DNA and RFC. (B) Titration of the concentration of Rad6–Rad18 in poly-ubiquitylation reactions on puriﬁed, partially poly-
ubiquitylated PCNA conﬁrms that Rad6–Rad18 is dispensable for chain extension. Rad6–Rad18 concentration was varied from 200 to 800nM.
(C) Loading of PCNA enhances the efﬁciency of chain extension by Ubc13–Mms2–Rad5. Poly-ubiquitylation reactions on puriﬁed, partially
mono-ubiquitylated PCNA were performed as described above, but adding DNA and RFC separately as indicated.
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with the ubiquitin derivatives indicated that all forms were
attached to the substrate with similar efﬁciency when present
as the only source of ubiquitin. The reduced thioester forma-
tion with K63-tetra-ubiquitin was not limiting for PCNA
modiﬁcation. However, when an equimolar mixture of
mono-, di- and tetra-ubiquitin of K63 linkage was used,
di- and particularly mono-ubiquitin were strongly preferred
over the tetramer. Likewise, minor contaminations of mono-
ubiquitin in the K48-di- and tetra-ubiquitin preparations that
had negligible effect in the thioester assay (Figure 5A) gave
rise to noticeable quantities of mono-ubiquitylated PCNA
(Figure 5B). These observations suggest that despite the
ability to use polymeric ubiquitin for thioester formation
and transfer, mono-ubiquitin is the preferred moiety for
transfer to PCNA by Rad6–Rad18, arguing against model D
(Figure 1).
In order to assess the validity of model B, we performed
analogous experiments for the chain extension step. The
pattern of thioester formation by Ubc13 was very similar to
that obtained with Rad6, in that the efﬁciency was reduced
with K63-tetra-ubiquitin, but comparable for all other
derivaties (Figure 5C). Addition of Mms2 and Rad5 did not
signiﬁcantly change this pattern (Supplementary Figure 1B).
Chain extension reactions were initially performed with the
HisUb–PCNA fusion, as this was modiﬁed by Ubc13–Mms2–
Rad5 with similar efﬁciency as K164-mono-ubiquitylated
PCNA. We found that all derivatives were efﬁciently attached
to the substrate (Figure 5D), indicating that preformed chains
of varying linkage can be used by Ubc13–Mms2–Rad5 on
PCNA for chain extension. As expected, only one moiety of
the K63R ubiquitin mutant was attached to
HisUb–PCNA.
Based on substrate depletion, K48 chains were less effectively
used than K63 chains, and whereas multiple units of K48- and
K63-di-ubiquitin were attached,
HisUb–PCNA was modi-
ﬁed by no more than a single unit of K48-tetra-ubiquitin.
In the case of K63-tetra-ubiquitin, single modiﬁcation
predominated, but higher forms were detectable as well.
Figure 4 Inﬂuence of the ubiquitin attachment site on poly-ubiquitin chain formation. (A) Rad5 stimulates the polymerisation of free ubiquitin
by Ubc13 and Mms2. Chain synthesis assays were performed in the absence of PCNA under our standard reaction conditions, using Ubc13–
Mms2 at concentrations where chains above di-ubiquitin are formed inefﬁciently (200nM). Rad5 concentration was varied from 25 to 200nM.
Replacement of ubiquitin by a K63R mutant is indicated as ‘R’. (B–E) Linear N- and C-terminal fusions of ubiquitin to PCNA can be poly-
ubiquitylated by Ubc13–Mms2–Rad5. (B) Chain extension reactions with Rad5, Ubc13 and Mms2 as indicated were carried out for 30min using
the N-terminal ubiquitin fusion,
HisUb–PCNA, as a substrate. DNA and RFC were added for loading of the fusion protein where indicated. (C)
The same reactions as in panel B were performed with the C-terminal ubiquitin fusion,
HisPCNA–Ub, for 60min. (D) Time-course experiments
were performed with
HisUb–PCNA in order to compare the efﬁciency of chain elongation in the loaded versus the unloaded state. (E) Titration
of RFC in the presence and absence of DNA indicates that loading stimulates poly-ubiquitylation of
HisUb–PCNA, whereas high concentrations
of RFC in the absence of DNA inhibit the reaction. RFC concentration was varied from 2.5 to 20nM.
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mono-ubiquitin and for K63- over K48-di-ubiquitin, although
the rate of tetra-ubiquitin attachment appeared similar for the
two linkages (Supplementary Figure 2). The modiﬁcation
pattern on physiologically K164-mono-ubiquitylated PCNA
was very similar and was not inﬂuenced by the presence of
DNA and RFC, although the overall efﬁciency of the reaction
was enhanced (Figure 5E). These results indicate some
linkage speciﬁcity with respect to the use of preformed chains
by Ubc13–Mms2–Rad5 and a slight preference for attachment
of monomers over chains. The notion that K63-tetra-ubiquitin
was used by Ubc13–Mms2–Rad5 for chain extension despite
the inefﬁciency of thioester formation indicates that the latter
was not rate-limiting in our reactions. Considering that this
might be different under physiological conditions, transfer of
longer poly-ubiquitin units en bloc by Ubc13–Mms2–Rad5 is
rather unlikely. Our data, thus, provide support for model A
(Figure 1), although some use of short chains cannot be
excluded, as the enzymes involved are in principle capable of
transferring poly-ubiquitin units.
Discussion
Our efforts to reconstitute PCNA modiﬁcation in vitro have
given important insights into a mechanism of poly-ubiquitin
chain formation that is distinct from previously analysed
examples. In contrast to many reported cases where a single
E2–E3 pair mediates both attachment of the ﬁrst ubiquitin
moiety to the substrate and extension to a polymeric chain,
poly-ubiquitylation of PCNA involves cooperation of two
Figure 5 Transfer of preformed ubiquitin chains by Rad6–Rad18 and Ubc13–Mms2–Rad5. Abbreviations for ubiquitin derivatives are as
follows: ‘R’, K63R mutant; ‘di’ and ‘tet’, di-ubiquitin and tetra-ubiquitin chains of K48- or K63-linkage as indicated; ‘M’, an equimolar mixture
of mono-, di- and tetra-ubiquitin (K63 linkage). (A) Rad6 is capable of forming thioesters with di- and tetra-ubiquitin. Reactions containing E1,
ATP, the indicated ubiquitin derivatives and Rad6 were analysed by Western blotting with a Rad6-speciﬁc antibody under reducing and non-
reducing conditions in order to assess thioester formation. (B) Rad6–Rad18 can transfer preformed di- or tetra-ubiquitin moieties onto loaded
PCNA. Mono-ubiquitylation reactions were performed under standard conditions in the presence of DNA and RFC with the indicated ubiquitin
derivatives. (C) Ubc13 is capable of forming thioesters with di- and tetra-ubiquitin. Thioester assays were performed with Ubc13 as in panel A
and analysed by Western blotting with a Ubc13-speciﬁc antibody. (D) Ubc13–Mms2–Rad5 can attach preformed di- or tetra-ubiquitin to the N-
terminal ubiquitin-PCNA fusion,
HisUb–PCNA. Chain extension reactions were performed under standard conditions with the indicated
ubiquitin derivatives. (E) Ubc13–Mms2–Rad5 can attach preformed di- or tetra-ubiquitin to PCNA mono-ubiquitylated at K164. Chain
extension reactions were performed with puriﬁed, partially mono-ubiquitylated PCNA as in panel D, either in the presence or in the absence of
DNA and RFC.
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Ubc13–Mms2–Rad5. Our results indicate that there is a clear
separation of tasks between the two complexes.
Mechanism of cooperation between Rad6–Rad18
and Ubc13–Mms2–Rad5
Previous information about the properties of the conjugation
factors involved in PCNA modiﬁcation gave rise to several
alternative models of how poly-ubiquitylation might be
mediated (Figure 1). On the one hand, physical interactions
between the E3s and their cognate E2s suggested the exis-
tence of a complex in which both E2–E3 pairs are present
(Bailly et al, 1994; Ulrich and Jentsch, 2000; Ulrich, 2003). In
addition, Rad18 is known to dimerise and form a hetero-
tetramer with Rad6 (Ulrich and Jentsch, 2000; Notenboom
et al, 2007). These notions suggested that there might be
dedicated complexes for mono- versus poly-ubiquitylation of
PCNA, consisting of either Rad6–Rad18 alone or of all ﬁve
components, according to models C and D (Figure 1). On the
other hand, both Rad18 and Rad5 interact directly with PCNA
and could, thus, in principle recognise their substrate inde-
pendently (Hoege et al, 2002). It was, therefore, important to
determine whether Rad6 both Rad18 was required for the
chain extension step or whether puriﬁed mono-ubiquitylated
PCNA could serve as a substrate for modiﬁcation by Ubc13
both Mms2 both Rad5 alone. Our experiments have now
shown that the latter is clearly the case, lending support to
models A and B, and effectively ruling out models C and D
(Figure 1). Hence, despite their interaction, Rad18 and Rad5
do not follow the strategy of heterodimeric RING E3s such as
the BRCA1–BARD or the RING1b–BMI1 complex, where
activity depends on dimerisation (Hibbert et al, 2009). The
notion that Rad18 and Rad5 interact with each other by
means of domains distinct from their RING ﬁngers (Ulrich
and Jentsch, 2000; Notenboom et al, 2007) argues against a
BRCA1–BARD1-like mode of operation as well.
Mechanism of ubiquitin transfer
A second basic question about the mechanism of chain
assembly concerned the nature of the ubiquitin species
transferred by the E2s. We sought to assess whether Rad6
and Ubc13 are capable of transferring ubiquitin chains en
bloc to their substrate in a Ube2g2-like manner (Figure 1B
and D), or whether they work in a stepwise manner by
transferring only monomers (Figure 1A and C). Self-interac-
tions of both Rad18 and Rad5 suggested that they might bring
two E2 molecules into close proximity, thereby allowing a
‘see-saw’ action where a chain could be built up on the
active-site cysteine of the E2s by addition to the proximal
end (Hochstrasser, 2006). Alternatively, free chains might be
extended through their distal end and activated by E1, a
mechanism supported by the high efﬁciency with which
Ubc13 and Mms2 promote the assembly of unanchored
poly-ubiquitin chains (Hofmann and Pickart, 2001; Ulrich,
2003). Without clarifying whether chains are synthesised on
the active-site cysteine of the E2 or free in solution, our
experiments indicate that although preformed chains can be
accepted and transferred by both Rad6–Rad18 and Ubc13–
Mms2–Rad5, both complexes—particularly Rad6–Rad18—
prefer ubiquitin monomers. In addition, the kinetics of
chain assembly indicated the formation of di- and tri-ubiqui-
tylated PCNA as transient intermediates that were depleted in
the course of the reaction, again arguing for a stepwise chain
assembly. Considering the independent action of the two E2–
E3 pairs, our data, therefore, strongly support the validity of
model A (Figure 1A), although they do not completely rule
out the use of short ubiquitin oligomers to some extent.
Relevance of substrate recognition by Rad5
Our evidence in support of model A raises the question of
how Rad5 recognises mono-ubiquitylated PCNA as a sub-
strate for chain extension independently of Rad18. In contrast
to the latter, Rad5 is only mildly responsive to the loading
state of the clamp, as the addition of DNA and RFC to the
reaction provided only minor enhancements to the efﬁciency
of the Rad5-catalysed step. In addition, Rad5 has previously
been shown to interact with (presumably) unmodiﬁed PCNA
(Hoege et al, 2002). Moreover, the site of mono-ubiquitin
attachment on the clamp is apparently not relevant for
recognition by Rad5, as linear fusions of mono-ubiquitin to
the N- or C-terminus of PCNA were both modiﬁed by Ubc13–
Mms2–Rad5. It is, therefore, likely that Rad5’s task in chain
extension is on the one hand a bridging function that brings
the Ubc13–Mms2 dimer into close proximity to PCNA, and on
the other hand a stimulation of E2 activity, for example by
acceleration of either thioester formation or thioester dis-
charge. Additional interaction between Rad5 and Rad18 in
vivo could then guide the Ubc13–Mms2–Rad5 complex pre-
ferentially to loaded PCNA that has been mono-ubiquitylated
by Rad6–Rad18 (Davies et al, 2008). According to this
scenario, Rad5 would not be involved in the recognition of
the ubiquitin moiety on mono-ubiquitylated PCNA, but it
would be the main determinant that directs the speciﬁcity of
Ubc13–Mms2 towards PCNA, while the E2 complex, by
means of the Mms2 subunit, would be responsible for
ubiquitin binding.
Strategies to catalyse poly-ubiquitin chain formation
It is instructive to compare the mechanism of Rad6–Rad18
and Ubc13–Mms2–Rad5 to that of other E2–E3 pairs capable
of poly-ubiquitin chain assembly. The notion that enzymes
such as the SCF
Cdc4 complex with the E2–Cdc34 (Petroski and
Deshaies, 2005) or human APC with the E2 UbcH10 (Jin et al,
2008) manage to catalyse both chain initiation and elongation
on a physiological substrate raises the question of why
separate complexes are needed for the two steps of PCNA
modiﬁcation. A clue to this problem may come from differ-
ences in substrate- versus ubiquitin-recognition: The SCF
Cdc4
catalyses poly-ubiquitin K48-speciﬁc chain assembly in a
highly processive reaction that depends on the presence
of an acidic loop within Cdc34 and on a hydrophobic patch
in ubiquitin adjacent to the K48-acceptor site (Petroski
and Deshaies, 2005). In contrast, recognition of the substrate
is less efﬁcient, does not require the acidic loop in Cdc34 and
is not restricted to a particular lysine. This arrangement
facilitates processive synthesis of K48-linked chains on a
variety of substrates, but it renders the ﬁrst step, the initiation
of the chain, rate-limiting. Human APC with UbcH10
appears to operate according to a different strategy, as it
requires a distinct sequence motif, the TEK box, in both the
substrate and ubiquitin for modiﬁcation (Jin et al, 2008). TEK
boxes are found on several APC substrates involved in
cell-cycle control and were suggested to provide a speciﬁc
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ubiquitin, a TEK box surrounds K11, the residue used for
chain extension. Chain initiation and elongation, therefore,
appear to obey the same criterion, even though additional
substrate lysines outside the TEK boxes may also function as
acceptor sites.
Finally, there are several examples of E3 enzymes that can
use distinct E2s to achieve mono- or poly-ubiquitylation,
respectively. Budding-yeast APC, which catalyses the forma-
tion of K48-linked poly-ubiquitin chains on its substrates,
uses two distinct E2s for chain initiation and elongation,
respectively (Rodrigo-Brenni and Morgan, 2007). While
Ubc4 mediates rapid, non-selective modiﬁcation of substrate
lysines, Ubc1 speciﬁcally mediates chain extension on pre-
attached ubiquitin moieties. This activity is supported by the
presence of a ubiquitin-binding UBA domain within Ubc1,
indicating that Ubc1 specialises in ubiquitin recognition,
whereas Ubc4 is responsible for substrate recognition. A
similar strategy is followed by the viral ubiquitin ligase K3,
which employs members of the Ubc5 E2 family for mono-
ubiquitylation of cell-surface MHC class-I molecules and
subsequently cooperates with Ubc13–Mms2 in the assembly
of a K63-linked poly-ubiquitin chain for downregulation of
the receptor by endocytosis (Duncan et al, 2006). The
BRCA1–BARD1 complex is capable of cooperating with sev-
eral different E2s in auto-ubiquitylation reactions in vitro, the
identity of the E2 determining either attachment of mono-
ubiquitin or extension to poly-ubiquitin chains of either
K48- or K63-linkage (Christensen et al, 2007).
PCNA poly-ubiquitylation appears to proceed in a manner
most similar to that of yeast APC, K3 and BRCA1–BARD1 in
that substrate selection and ubiquitin recognition are
achieved by distinct enzymes. Whereas Rad6–Rad18 is highly
selective for a single lysine on PCNA, K164 (Hoege et al,
2002; Garg and Burgers, 2005), Ubc13–Mms2, aided by Rad5,
exclusively attaches ubiquitin to other ubiquitin moieties.
Ubiquitin recognition in this case is mediated by the Mms2
subunit and requires the hydrophobic patch on the ubiquitin
surface (McKenna et al, 2001). A major difference between
E3s like SCF or APC and the enzymes involved in PCNA
modiﬁcation, however, is their range of physiological sub-
strates. Whereas SCF and APC target a variety of proteins for
degradation, Rad6–Rad18 has an extremely narrow substrate
range. Its exclusive selectivity for a unique site on PCNA may
explain why the complex is not only inefﬁcient, but appar-
ently completely unable to attach more than a single ubiqui-
tin moiety to its substrate. It may also be the reason for why
Ubc13–Mms2—in contrast to Ubc1—requires a second E3 for
stimulation of chain formation. Finally, the notion that mono-
ubiquitylated PCNA has a physiological function distinct
from that of the poly-ubiquitylated form and may exhibit
different regulatory requirements, might also have favoured
the evolution of a seemingly complicated two-step modiﬁca-
tion system.
Poly-ubiquitylation by dedicated conjugation factors is not
an isolated phenomenon in vivo. Chain elongation factors
such as E4 enzymes can redirect the linkage of a poly-
ubiquitin chain to one that is suitable for mediating degrada-
tion (Koegl et al, 1999), and proteasome-associated ubiquitin
ligases such as Hul5 can extend the poly-ubiquitin chains on
pre-modiﬁed substrates, thus apparently enhancing the efﬁ-
ciency of proteolysis (Leggett et al, 2002; Crosas et al, 2006).
Their mechanistic analysis will most likely reveal an even
wider variety of possible mechanisms of ubiquitin chain
assembly.
Materials and methods
Proteins
Recombinant budding-yeast PCNA (untagged),
HisUbc13, Mms2 and
RFC were produced as previously described (Ulrich, 2003; Franco
et al, 2005; Parker et al, 2008). All of them were subjected to a ﬁnal
gel-ﬁltration step for puriﬁcation. Human
HisUba1 (E1) was
purchased from BioMol and ubiquitin and its derivatives were
from Boston Biochem. The Rad6–Rad18 complex was produced by
overexpression of
HisRAD18 from the vector pYES2 (Invitrogen) in
the protease-deﬁcient S. cerevisiae strain BJ5460 (ATCC no.
208285), which additionally carried an overexpression construct
for RAD6 under control of the ADH1 promoter. Expression of
HisRAD18 was induced in cultures growing exponentially in uracil-
free medium containing 0.1% glucose through the addition of
galactose to 2% and further incubation for 20h. The pellet from an
8-l culture was resuspended in buffer A (50mM Tris–HCl (pH 8.0),
300mM NaCl, 10% glycerol) containing 15mM imidazole and
Complete protease inhibitors (Roche) and lysed by high-pressure
cell disruption. All steps were carried out at 41C. The lysate was
cleared by centrifugation at 40000g for 20min and then at 150000g
for 45min. The cleared lysate was subjected to Ni–NTA agarose
afﬁnity puriﬁcation. Bound protein was eluted in buffer B (40mM
HEPES (pH 7.4), 10% glycerol) containing 200mM imidazole and
200mM NaCl. Fractions containing Rad6–Rad18 were pooled and
applied to a 5ml Hi Trap Heparin column (GE Bioscience)
equilibrated in buffer Bþ200mM NaCl. Proteins were eluted with
a gradient from 200 to 500mM NaCl. Following MonoQ chromato-
graphy (1ml column), fractions containing Rad6–Rad18 were
pooled and subjected to ﬁltration a Superdex 200 gel-ﬁltration
column equilibrated in buffer Bþ150mM NaCl. The puriﬁed
protein was stored at  801C. Rad5, bearing an N-terminal His6
epitope, was puriﬁed from BJ5460 essentially like Rad6–Rad18, but
the MonoQ column chromatography step was omitted. N- and C-
terminal fusions of ubiquitin to PCNA (
HisUb–PCNA and
HisPCNA–
Ub) were constructed as described previously (Parker et al, 2007),
but using WT ubiquitin. K127 and K164 of PCNA were mutated to
arginine. G76 of ubiquitin was mutated to valine in the N-terminal
fusion, and the two C-terminal glycines were deleted in the C-
terminal fusion. Proteins were produced in E. coli and puriﬁed by
Ni–NTA agarose chromatography and subsequent gel ﬁltration into
a buffer containing 40mM HEPES (pH 7.4), 150mM NaCl, 10%
glycerol and 1mM DTT. Rad6 used for thioester assays was
produced and puriﬁed from E. coli using an intein fusion system
based on the vector pTYB12 (New England Biolabs) according to
the manufacturer’s instructions.
PCNA mono-ubiquitylation reactions
In vitro ubiquitylation assays were performed essentially as
described previously (Garg and Burgers, 2005). A 10-ml standard
assay contained 40mM HEPES (pH 7.4), 50mM NaCl, 8mM
magnesium acetate, 1mM ATP, 30fmol of nicked pBluescript
plasmid DNA, 0.5pmol of PCNA trimer, 0.2pmol of RFC, 2pmol
of Rad6Rad18, 0.5pmol of
HisUba1 (E1) and 10pmol of ubiquitin.
Reactions were incubated at 301C for 60min unless stated
otherwise, stopped through addition of SDS loading buffer and
denatured at 951C for 3min. Products were analysed by 10% SDS–
polyacrylamide gel electrophoresis (PAGE) and Western blotting
with a polyclonal PCNA-speciﬁc antibody.
Puriﬁcation of mono-ubiquitylated PCNA
PCNA was ubiquitylated in a 2-ml reaction as described above, but
using human His6-tagged ubiquitin. Benzonase (Novagen) was
added for 15min to degrade the DNA. The reaction was diluted 1:1
in buffer A (40mM HEPES (pH 7.4), 10% glycerol) and passed
through a 1ml HiTrap Heparin column equilibrated in buffer
Aþ100mM NaCl. Imidazole was added to the eluate to a ﬁnal
concentration of 30mM, and the preparation was subjected to Ni–
NTA agarose puriﬁcation. Free ubiquitin was removed by binding
the modiﬁed PCNA to a 1ml HiTrap Q column and washing
extensively with buffer Aþ200mM NaCl. Modiﬁed PCNA was
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dialysed against buffer Aþ100mM NaCl and stored at  801C.
Chain extension assays
Poly-ubiquitylation of unmodiﬁed PCNAwas carried out essentially
like the mono-ubiquitylation reactions, but 2pmol each of Rad5,
Ubc13 and Mms2 were added after a 40-min incubation with Rad6–
Rad18. The reactions mixtures were incubated for a further 40min.
For chain extension assays with puriﬁed mono-ubiquitylated PCNA
or the ubiquitin-PCNA fusions, the reaction mixtures were
incubated at 301C for 60min (30min for
HisUb–PCNA).
Free ubiquitin chain synthesis
Ubiquitin chain synthesis was analysed in 10-ml reactions in 40mM
HEPES (pH 7.4), 50mM NaCl, 8mM magnesium acetate, 1mM ATP,
0.5pmol of E1 and 100pmol of ubiquitin. 2pmol each of Ubc13
and Mms2 were added and 0.25–2pmol of Rad5. Reactions were
incubated at 301C for 60min, stopped through addition of SDS
loading buffer and denatured at 951C for 3min. Products were
analysed by SDS–PAGE and Western blots using a monoclonal
ubiquitin-speciﬁc antibody.
Thioester assays with Rad6 and Ubc13
Standard reactions of 20ml were performed in 40mM HEPES (pH
7.4), 50mM NaCl, 8mM magnesium acetate, 1mM ATP, containing
2pmol of
HisUba1 and 20pmol of ubiquitin or ubiquitin chains. The
relevant E2 (4pmol) was added and reactions were incubated at
301C for 20min. Aliquots of 9ml each were added to 9mlo fH U
loading buffer without a reducing agent (8M urea, 200mM Tris–HCl
(pH 6.8), 1mM EDTA, 5% SDS, 0.1% bromophenol blue) or 9ml
of 2  SDS loading buffer containing 200mM dithiothreitol as
reducing agent. Reduced and non-reduced samples were incubated
at 951C for 5min and at 501C for 15min, respectively. Samples were
analysed by 12% SDS–PAGE and Western blotting with polyclonal
antibodies speciﬁc to Rad6 or Ubc13.
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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